ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.

Christoph Wiessner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.